[Erythropoietin resistance].
Branger
Bernard
B
D000535:Aluminum / Q000009:adverse effects; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000747:Anemia, Hypochromic / Q000188:drug therapy; D004351:Drug Resistance; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D000090463:Iron Deficiencies; D007518:Isoantibodies / Q000276:immunology; D009748:Nutrition Disorders / Q000150:complications; D055728:Primary Myelofibrosis / Q000150:complications; D011994:Recombinant Proteins / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D006435:Renal Dialysis; D017211:Treatment Failure
D018836:Inflammation Mediators; D007518:Isoantibodies; D011994:Recombinant Proteins; D004921:Erythropoietin; D000535:Aluminum